0.00Open0.00Pre Close0 Volume0 Open Interest155.00Strike Price0.00Turnover0.00%IV40.36%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma346.50Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Clean Harbors Stock Discussion
• $Arcus Biosciences (RCUS.US)$ +11.2% (appointed to join S&P SmallCap 600)
• $Sphere 3d (ANY.US)$ +10.13% (mutually agreed to terminate merger agreement with Gryphon Digital Mining)
• $Theravance Biopharma (TBPH.US)$ +3.05% (announced results from Study 0170)
• $Carnival (CUK.US)$ +4.7% (reported that March 28-April 3 was the busiest booking week in company history)
• $Castle Biosciences (CSTL.US)$ +4.4% (agreed to acquire Althe...
• $Clean Harbors (CLH.US)$ : Goldman Sachs Upgrades to Neutral from Sell - PT $120
• $EZCORP (EZPW.US)$ : Jefferies Upgrades to Buy From Hold - PT $8.50
• $First Republic Bank (FRC.US)$ : Credit Suisse Upgrades to Neutral From Underperform - PT $187
• $Generac (GNRC.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $410
• $Teva Pharmaceutical Industries (TEVA.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $13 (from $11)
• $Xylem (XYL.US)$ ...
No comment yet